AU545747B2 - Pyridine derivatives - Google Patents

Pyridine derivatives

Info

Publication number
AU545747B2
AU545747B2 AU81873/82A AU8187382A AU545747B2 AU 545747 B2 AU545747 B2 AU 545747B2 AU 81873/82 A AU81873/82 A AU 81873/82A AU 8187382 A AU8187382 A AU 8187382A AU 545747 B2 AU545747 B2 AU 545747B2
Authority
AU
Australia
Prior art keywords
acid addition
acceptable acid
pharmaceutically acceptable
pyridine
addition salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU81873/82A
Other languages
English (en)
Other versions
AU8187382A (en
Inventor
Jean Binet
Icilio Cavero
Philippe Manoury
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Publication of AU8187382A publication Critical patent/AU8187382A/en
Application granted granted Critical
Publication of AU545747B2 publication Critical patent/AU545747B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU81873/82A 1981-03-25 1982-03-24 Pyridine derivatives Ceased AU545747B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8106005A FR2502618A1 (fr) 1981-03-25 1981-03-25 Derives de pyridine, leur preparation et leur application en therapeutique
FR8106005 1981-03-25

Publications (2)

Publication Number Publication Date
AU8187382A AU8187382A (en) 1982-09-30
AU545747B2 true AU545747B2 (en) 1985-08-01

Family

ID=9256643

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81873/82A Ceased AU545747B2 (en) 1981-03-25 1982-03-24 Pyridine derivatives

Country Status (20)

Country Link
US (1) US4406907A (enFirst)
EP (1) EP0061379B1 (enFirst)
JP (1) JPS57169462A (enFirst)
AR (1) AR231281A1 (enFirst)
AT (1) ATE15895T1 (enFirst)
AU (1) AU545747B2 (enFirst)
CA (1) CA1185978A (enFirst)
DE (1) DE3266607D1 (enFirst)
DK (1) DK156652C (enFirst)
ES (1) ES8303346A1 (enFirst)
FI (1) FI75808C (enFirst)
FR (1) FR2502618A1 (enFirst)
GR (1) GR75930B (enFirst)
HU (1) HU186488B (enFirst)
IE (1) IE52654B1 (enFirst)
IL (1) IL65336A (enFirst)
MX (1) MX156114A (enFirst)
NO (1) NO159850C (enFirst)
NZ (1) NZ200118A (enFirst)
ZA (1) ZA822008B (enFirst)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6218598A (en) * 1997-01-30 1998-08-25 Synthelabo Alpha-azacyclomethyl benzothiophene and alpha-azacyclomethyl benzofurane derivatives, preparation and therapeutic application
FR2758820B1 (fr) * 1997-01-30 1999-02-26 Synthelabo Derives de alpha-azacyclomethyl-benzofurane, leur preparation et leur application en therapeutique
CN113490670B (zh) 2019-08-05 2023-06-02 北京志健金瑞生物医药科技有限公司 含氮多环稠环类化合物,其药物组合物、制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195090A (en) * 1973-02-20 1980-03-25 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)pyridine derivatives and pharmaceutical compositions therewith
US4115575A (en) * 1973-02-20 1978-09-19 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-pyrazines
AR206801A1 (es) * 1973-02-20 1976-08-23 Ciba Geigy Ag Procedimiento para la elaboracion de derivados del 1-pirid loxi-2-hidroxi-3-amino-propano

Also Published As

Publication number Publication date
ES510724A0 (es) 1983-02-01
AU8187382A (en) 1982-09-30
IL65336A (en) 1985-08-30
IE820682L (en) 1982-09-25
JPS57169462A (en) 1982-10-19
FI821034A0 (fi) 1982-03-24
FR2502618A1 (fr) 1982-10-01
HU186488B (en) 1985-08-28
EP0061379A1 (fr) 1982-09-29
ZA822008B (en) 1983-02-23
DK156652C (da) 1990-02-05
US4406907A (en) 1983-09-27
FI821034L (fi) 1982-09-26
DK133282A (da) 1982-09-26
MX156114A (es) 1988-07-12
FR2502618B1 (enFirst) 1983-12-23
IE52654B1 (en) 1988-01-06
CA1185978A (en) 1985-04-23
NO159850B (no) 1988-11-07
FI75808C (fi) 1988-08-08
FI75808B (fi) 1988-04-29
NO159850C (no) 1989-02-15
NZ200118A (en) 1984-09-28
NO820979L (no) 1982-09-27
ES8303346A1 (es) 1983-02-01
AR231281A1 (es) 1984-10-31
ATE15895T1 (de) 1985-10-15
GR75930B (enFirst) 1984-08-02
IL65336A0 (en) 1982-05-31
EP0061379B1 (fr) 1985-10-02
JPS6135185B2 (enFirst) 1986-08-12
DE3266607D1 (en) 1985-11-07
DK156652B (da) 1989-09-18

Similar Documents

Publication Publication Date Title
AU559140B2 (en) Perhydrobicyclopyrtolyl-aminoacid derivatives
AU559727B2 (en) Cephalosphorin derivatives
AU553462B2 (en) Oxazolidinone-2 derivatives
AU555213B2 (en) N-substituted-amido-fluoresein derivatives
AU544877B2 (en) Dichloroquinoline derivatives
AU552896B2 (en) Alkanesulfonanilide derivatives
AU560003B2 (en) Acylquinoline derivatives
AU2274783A (en) Pyridine derivatives
AU2222083A (en) Pyridine derivatives
AU541200B2 (en) Cyclopentapiene derivatives
AU549479B2 (en) Azolyl-phenoxy derivatives
AU547799B2 (en) Pyridine derivatives
AU561210B2 (en) Pyridine derivatives
AU551532B2 (en) Substituted pyridines
AU554428B2 (en) Benzisoxazol-3yl derivatives
AU1045283A (en) Substituted pyridines
AU554243B2 (en) Benzylazole derivatives
AU544455B2 (en) Apovincaminol derivatives
AU8187382A (en) Pyridine derivatives
AU8444982A (en) 4-amino-benzylamine derivatives
AU556771B2 (en) Cyclohexeny pyridine derivatives
AU546848B2 (en) Imidezole derivatives
AU545745B2 (en) Apovincaminol derivatives
AU8975482A (en) 2-ethylsulphonyl pyridine-1-oxide derivatives
AU2369984A (en) Pyridine derivatives